SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-011556
Filing Date
2022-08-02
Accepted
2022-08-02 08:01:10
Documents
85
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hrmy-20220630x10q.htm   iXBRL 10-Q 1465222
2 EX-10.1 hrmy-20220630xex10d1.htm EX-10.1 13785
3 EX-31.1 hrmy-20220630xex31d1.htm EX-31.1 16268
4 EX-31.2 hrmy-20220630xex31d2.htm EX-31.2 16842
5 EX-32.1 hrmy-20220630xex32d1.htm EX-32.1 9970
6 EX-32.2 hrmy-20220630xex32d2.htm EX-32.2 9466
  Complete submission text file 0001558370-22-011556.txt   7151000

Data Files

Seq Description Document Type Size
7 EX-101.SCH hrmy-20220630.xsd EX-101.SCH 57263
8 EX-101.CAL hrmy-20220630_cal.xml EX-101.CAL 68574
9 EX-101.DEF hrmy-20220630_def.xml EX-101.DEF 171104
10 EX-101.LAB hrmy-20220630_lab.xml EX-101.LAB 477656
11 EX-101.PRE hrmy-20220630_pre.xml EX-101.PRE 356011
79 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20220630x10q_htm.xml XML 1302157
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39450 | Film No.: 221126925
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences